A detailed history of Wells Fargo & Company transactions in Tela Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 16,718 shares of TELA stock, worth $47,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,718
Holding current value
$47,646
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.32 - $5.04 $38,785 - $84,258
16,718 New
16,718 $42,000
Q1 2024

May 10, 2024

BUY
$5.3 - $7.61 $3,434 - $4,931
648 Added 15.47%
4,836 $27,000
Q4 2023

Feb 09, 2024

BUY
$4.5 - $7.51 $4,297 - $7,172
955 Added 29.54%
4,188 $27,000
Q3 2023

Nov 13, 2023

SELL
$7.85 - $10.68 $26,682 - $36,301
-3,399 Reduced 51.25%
3,233 $25,000
Q2 2023

Aug 15, 2023

BUY
$9.23 - $11.23 $60,484 - $73,590
6,553 Added 8294.94%
6,632 $67,000
Q1 2023

May 12, 2023

BUY
$9.41 - $12.03 $9 - $12
1 Added 1.28%
79 $0
Q4 2022

Feb 13, 2023

BUY
$6.5 - $11.5 $208 - $368
32 Added 69.57%
78 $0
Q3 2022

Nov 14, 2022

SELL
$7.36 - $9.15 $7 - $9
-1 Reduced 2.13%
46 $0
Q2 2022

Aug 12, 2022

BUY
$5.54 - $11.49 $22 - $45
4 Added 9.3%
47 $0
Q4 2021

Feb 14, 2022

BUY
$11.95 - $13.34 $11 - $13
1 Added 2.38%
43 $1,000
Q3 2021

Nov 15, 2021

SELL
$12.2 - $15.93 $97 - $127
-8 Reduced 16.0%
42 $1,000
Q2 2021

Aug 16, 2021

SELL
$11.7 - $16.11 $23,903 - $32,912
-2,043 Reduced 97.61%
50 $1,000
Q1 2021

May 13, 2021

SELL
$12.84 - $17.26 $85,707 - $115,210
-6,675 Reduced 76.13%
2,093 $31,000
Q4 2020

Feb 09, 2021

BUY
$14.61 - $17.59 $102,781 - $123,745
7,035 Added 405.94%
8,768 $132,000
Q3 2020

Nov 05, 2020

SELL
$11.64 - $16.86 $12,175 - $17,635
-1,046 Reduced 37.64%
1,733 $29,000
Q2 2020

Aug 13, 2020

BUY
$7.75 - $22.61 $21,335 - $62,245
2,753 Added 10588.46%
2,779 $36,000
Q1 2020

May 14, 2020

BUY
$5.39 - $18.33 $140 - $476
26 New
26 $0

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $54.6M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.